Sun Pharma Advanced Research Company Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
4564.72 Cr.
|
P/BV
|
-58.99
|
Book Value (Rs.)
|
-2.38
|
52 Week High/Low (Rs.)
|
258/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
FaceValue | 1.00 | 1.00 |
| | |
PER SHARE RATIOS | | |
| | |
Basic EPS (Rs.) | -11.93 | -7.82 |
Diluted EPS (Rs.) | -11.93 | -7.82 |
Cash EPS (Rs.) | -11.55 | -6.50 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 3.88 | 15.80 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 3.88 | 15.80 |
Revenue From Operations / Share (Rs.) | 2.33 | 7.36 |
PBDIT / Share (Rs.) | -11.48 | -6.26 |
PBIT / Share (Rs.) | -11.87 | -6.62 |
PBT / Share (Rs.) | -11.92 | -6.86 |
Net Profit / Share (Rs.) | -11.93 | -6.86 |
NP After MI And SOA / Share (Rs.) | -11.93 | -6.86 |
| | |
PROFITABILITY RATIOS | | |
| | |
PBDIT Margin (%) | -493.24 | -85.09 |
PBIT Margin (%) | -509.80 | -90.01 |
PBT Margin (%) | -512.05 | -93.21 |
Net Profit Margin (%) | -512.55 | -93.21 |
NP After MI And SOA Margin (%) | -512.55 | -93.21 |
Return on Networth / Equity (%) | -307.91 | -43.40 |
Return on Capital Employeed (%) | -154.06 | -33.00 |
Return On Assets (%) | -75.18 | -26.81 |
Total Debt / Equity (X) | 0.37 | 0.00 |
Asset Turnover Ratio (%) | 0.11 | 0.00 |
| | |
LIQUIDITY RATIOS | | |
| | |
Current Ratio (X) | 1.02 | 2.54 |
Quick Ratio (X) | 1.02 | 2.54 |
| | |
COVERAGE RATIOS | | |
| | |
Interest Coverage Ratio (%) | -219.89 | -26.61 |
Interest Coverage Ratio (Post Tax) (%) | -227.50 | -28.15 |
| | |
VALUATION RATIOS | | |
| | |
Enterprise Value (Cr.) | 11897.66 | 5712.17 |
EV / Net Operating Revenue (X) | 157.49 | 23.92 |
EV / EBITDA (X) | -31.93 | -28.11 |
MarketCap / Net Operating Revenue (X) | 158.92 | 24.39 |
Price / BV (X) | 95.47 | 11.36 |
Price / Net Operating Revenue (X) | 158.93 | 24.39 |
EarningsYield | -0.03 | -0.03 |